You are here

  • Home
  • Archive
  • Volume 72, Issue 1
  • Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung

Article metrics

Article menu

Download PDFPDF

Chronic obstructive pulmonary disease
Original article
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung

 

Online download statistics by month:

Online download statistics by month: August 2016 to December 2020

AbstractFullPdf
Aug 2016707370205
Sep 201620919080
Oct 20168911993
Nov 20167110770
Dec 20161238212252
Jan 2017872161310
Feb 201711383117
Mar 2017412898
Apr 2017214661
May 2017314261
Jun 2017328646
Jul 201711411544
Aug 2017888445
Sep 2017686624
Oct 2017777134
Nov 2017585835
Dec 2017787646
Jan 201810610029
Feb 2018817941
Mar 20181019945
Apr 2018707040
May 201810410438
Jun 2018757527
Jul 20189212224
Aug 20188513331
Sep 20187011826
Oct 201814218842
Nov 201813318054
Dec 20186711717
Jan 20197912723
Feb 20199313526
Mar 20196911733
Apr 20199314032
May 2019666826
Jun 2019757435
Jul 2019685031
Aug 201910910227
Sep 2019978750
Oct 2019797129
Nov 2019494829
Dec 2019574822
Jan 2020705823
Feb 2020494528
Mar 20201036135
Apr 202018716565
May 2020837330
Jun 2020685542
Jul 2020745546
Aug 2020554012
Sep 2020795624
Oct 2020685640
Nov 2020906529
Dec 2020534721
Total686254422793